ARCHIVES

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

DCCP Board Okays Noncompetitive Procurements

June 11, 1982

NCI Alternative to Fixed Number Of Grants Not Popular At NIH; AACR Considers New Issues Groups

July 15, 1983

Rhoads Suggests Plan For 200 Clinical Centers

January 28, 1977

Center Seeks HER-2 Positive Breast Cancer Patients

August 29, 2003

Advocates Oppose Proposals to Market Drugs After Phase I.

June 9, 2006

Foreeman, Brinker, Jako Appointed To Cancer Panel

April 19, 1991